Cardiovascular risk assessment of the liver transplant candidate

Zankhana Raval, Matthew E. Harinstein, Anton I. Skaro, Ata Erdogan, Andre M. Dewolf, Sanjiv J. Shah, Oren K. Fix, Nina Kay, Michael I. Abecassis, Mihai Gheorghiade, James D. Flaherty*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

146 Scopus citations

Abstract

Liver transplantation (LT) candidates today are increasingly older, have greater medical acuity, and have more cardiovascular comorbidities than ever before. Steadily rising model for end-stage liver disease (MELD) scores at the time of transplant, resulting from high organ demand, reflect the escalating risk profiles of LT candidates. In addition to advanced age and the presence of comorbidities, there are specific cardiovascular responses in cirrhosis that can be detrimental to the LT candidate. Patients with cirrhosis requiring LT usually demonstrate increased cardiac output and a compromised ventricular response to stress, a condition termed cirrhotic cardiomyopathy. These cardiac disturbances are likely mediated by decreased beta-agonist transduction, increased circulating inflammatory mediators with cardiodepressant properties, and repolarization changes. Low systemic vascular resistance and bradycardia are also commonly seen in cirrhosis and can be aggravated by beta-blocker use. These physiologic changes all contribute to the potential for cardiovascular complications, particularly with the altered hemodynamic stresses that LT patients face in the immediate post-operative period. Post-transplant reperfusion may result in cardiac death due to a multitude of causes, including arrhythmia, acute heart failure, and myocardial infarction. Recognizing the hemodynamic challenges encountered by LT patients in the perioperative period and how these responses can be exacerbated by underlying cardiac pathology is critical in developing recommendations for the pre-operative risk assessment and management of these patients. The following provides a review of the cardiovascular challenges in LT candidates, as well as evidence-based recommendations for their evaluation and management.

Original languageEnglish (US)
Pages (from-to)223-231
Number of pages9
JournalJournal of the American College of Cardiology
Volume58
Issue number3
DOIs
StatePublished - Jul 12 2011

Keywords

  • coronary artery disease
  • end-stage liver disease
  • liver transplant

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Cardiovascular risk assessment of the liver transplant candidate'. Together they form a unique fingerprint.

Cite this